Lemon Healthcare to Expand Globally Using Medical Data Platform Ahead of IPO

Details

Ahead of its IPO, Lemon Healthcare announced an expansion strategy centered on its proprietary medical data relay platform, 'LDB'. The company emphasized its technical superiority in standardizing disparate hospital data—which is unique to each facility—and facilitating real-time calling, standardization, automatic conversion, and relay. Domestically, the company boasts a high market share of over 80%, having secured 38 out of 47 tertiary hospitals as clients. Furthermore, it has achieved a cumulative download count exceeding 13 million for its patient-centric smart hospital platform. Its growth strategy focuses on building complex barriers to entry—not just technical capability, but also customer trust and established medical institution networks. The company aims for a 'virtuous cycle' by utilizing over 100 million pieces of patient-consented data: improving the patient experience leads to expanding the data relay platform ecosystem, which in turn drives revenue growth. Global expansion was also mentioned; service launch is scheduled in Vietnam, and future plans include entering Southeast Asian markets such as Japan and Malaysia. The company intends to use IPO funds for enhancing its data platform, expanding AI-based data businesses, and investing in overseas markets.